-
Mashup Score: 0ASH 2017: Antibiotic Levofloxacin Reduces High Early Death Rate in Myeloma Patients - The Myeloma Crowd - 5 year(s) ago
The annual American Society of Hematology meeting is almost here, showcasing new findings
Source: www.myelomacrowd.orgCategories: Hem/OncsTweet
-
Mashup Score: 0
Should you get re-vaccinated after your stem cell transplant? Take a look at these guidelines from top myeloma facilities.
Source: www.myelomacrowd.orgCategories: Hem/OncsTweet-
Myeloma 101: Vaccinations After Myeloma Stem Cell Transplant [May 8, 2017] Paul Kleutghen @myelomacrowd https://t.co/13UjUvbhFB #mmsm #bmtsm #IDonc https://t.co/mnEqOHukup
-
-
Mashup Score: 0ASH 2017: Antibiotic Levofloxacin Reduces High Early Death Rate in Myeloma Patients - The Myeloma Crowd - 5 year(s) ago
The annual American Society of Hematology meeting is almost here, showcasing new findings
Source: www.myelomacrowd.orgCategories: Hem/OncsTweet-
#ASH17: Antibiotic Levofloxacin Reduces High Early Death Rate in Myeloma Patients [11/08/17] - by Eric Hansen @myelomacrowd https://t.co/xt7XyMv9ie #mmsm #IDonc
-
-
Mashup Score: 1
Do multiple myeloma patients need a flu shot booster? Yes and then some! Research presented at ASH shows myeloma patients need more protection than others.
Source: www.myelomacrowd.orgCategories: Hem/OncsTweet-
ASH 2017: Myeloma Patients Need a Flu Shot Booster! [12/10/17] Eric Hansen @myelomacrowd RE: Branagan et al. #ASH17 https://t.co/XWtopwiAm0 #mmsm #IDonc
-
-
Mashup Score: 0
Should you get re-vaccinated after your stem cell transplant? Take a look at these guidelines from top myeloma facilities.
Source: www.myelomacrowd.orgCategories: Hem/OncsTweet-
Myeloma 101: Vaccinations After Myeloma Stem Cell Transplant [May 8, 2017] Paul Kleutghen @myelomacrowd https://t.co/13UjUvbhFB #mmsm #bmtsm #IDonc https://t.co/qoPPtG6sSH
-
-
Mashup Score: 0MRD Testing Results for Multiple Myeloma Now Captured Inside of HealthTree - The Myeloma Crowd - 5 year(s) ago
You can now capture your Minimal Residual Disease (MRD) Testing results and add it to your full HealthTree profile. Just one more way HealthTree helps you keep all your myeloma info in a single place!
Source: www.myelomacrowd.orgCategories: Hem/OncsTweet-
MRD Testing Results for Multiple Myeloma Now Captured Inside of HealthTree - The Myeloma Crowd https://t.co/PHIw8SuH8o #myeloma
-
-
Mashup Score: 0A Coach's Perspective: Why I'll Be at the San Diego Myeloma Crowd Round Table - The Myeloma Crowd - 5 year(s) ago
You can join us in sunny San Diego on 3/7 and learn more about myeloma from many top myeloma specialists. It’s an amazing chance to ask your key questions!
Source: www.myelomacrowd.orgCategories: Hem/OncsTweet-
A Coach's Perspective: Why I'll Be at the San Diego Myeloma Crowd Round Table - The Myeloma Crowd https://t.co/ms4J33AsJd #mmsm
-
-
Mashup Score: 0New Test for Daratumumab (Darzalex) Patients Helps With M-Protein Accuracy - The Myeloma Crowd - 5 year(s) ago
There’s a new test for patients on daratumumab that can more accurately identify residual disease. FDA has given approval for this new test developed by Janssen and Sebia.
Source: www.myelomacrowd.orgCategories: Hem/OncsTweet-
New Test [Hydrashift 2/4] for Daratumumab (Darzalex) Patients Helps With M-Protein Accuracy [2/2/18] by Paul Kleutghen @myelomacrowd https://t.co/4EnEASpuOF #mmsm #camoldx HT @SparkCures
-
-
Mashup Score: 0ASH 2019: Venetoclax: The Good, the Bad and the Hopefuls - 5 year(s) ago
Venetoclax is FDA approved for use in certain types of leukemia. It proved to be useful for some leukemia patients with a chromosome 17 P deletion. For the past few years, Venetoclax has been the subject of several studies for use in myeloma. But it has been a bumpy road. During testing several patients died and the FDA, for a time, put a halt to the study. It is still unclear…
Source: www.myelomacrowd.orgCategories: Hem/OncsTweet-
ASH 2019: Venetoclax: The Good, the Bad and the Hopefuls - The Myeloma Crowd https://t.co/NxxmVD3qgY #ash19
-
#ASH17: Antibiotic Levofloxacin Reduces High Early Death Rate in Myeloma Patients [11/08/17] - by Eric Hansen @myelomacrowd https://t.co/xt7XyMv9ie #mmsm #IDonc